Consolidated Ordering System News Today

Branch County receives opioid lawsuit first payment adds another settlement

States that legalized cannabis use saw a significant reduction in pharmacy-based distribution of codeine, an opioid with a high potential for misuse, according to new research.

CHARLESTON — An official of the U.S. Drug Enforcement Administration told attorneys defending suppliers of opioid drugs that the companies were supposed to protect against suspicious drug orders without specific guidance from the DEA.

SEATTLE (Legal Newsline) - The last witness appeared on Monday in a trial that has gone on for more than four months accusing three of the country’s largest distributors of opioid pills of causing an overdose epidemic in Washington State.

SEATTLE (Legal Newsline) - It appeared on Thursday that defense attorneys for opioid drug distributor AmerisourceBergen were attempting to distance themselves from two other companies being sued by Washington State for allegedly causing an overdose epidemic.

Attorneys for the State of Washington and those defending three of the country’s biggest opioid pill distributors sparred this week over figures showing that drug ordering took a big jump around the year 2006.

CHARLESTON — Prescription painkillers played a major role in fatal overdoses in Huntington and Cabell County over a two-decade period, an epidemiologist said at a Charleston opioid trial Thursday.

SafeScript Pharmacies #6, is pictured on Feb. 20, 2012, in downtown Huntington. The target of a federal investigation, an analytics expert testified at a trial Monday against opioid wholesalers that prior to the pharmacys closure, AmerisourceBergen had been shipping it an average of 35,500 oxycodone doses a month, about seven times the national average.

CHARLESTON — Accusers in a lawsuit alleging opioid wholesalers have fault in the Cabell County and Huntington drug crisis used a “heroine,” scientist, historian, social worker and health expert to

× Thank you for Reading. Please log in, or sign up for a new account and purchase a subscription to continue reading. Please purchase a subscription to continue reading. Your current subscription does not provide access to this content.